Alerts will be sent to your verified email
Verify EmailCHEMOPH
Chemo Pharma Labs
|
Hamps Bio
|
Saroja Pharma Ind
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-4.51 % | 14.19 % | 33.33 % |
5yr average Equity Multiplier
|
1.01 | 2.36 | 4.66 |
5yr Average Asset Turnover Ratio
|
0.0 | 1.18 | 2.98 |
5yr Avg Net Profit Margin
|
0.0 | 5.23 % | 2.08 % |
Price to Book
|
1.37 | 2.05 | 0.0 |
P/E
|
0.0 | 59.55 | 17.48 |
5yr Avg Cash Conversion Cycle
|
0.0 | 74.76 Days | 80.28 Days |
Inventory Days
|
0.0 | 53.3 Days | 11.27 Days |
Days Receivable
|
0.0 | 59.7 Days | 122.72 Days |
Days Payable
|
0.0 | 80.45 Days | 47.62 Days |
5yr Average Interest Coverage Ratio
|
794.39 | 3.45 | 2.76 |
5yr Avg ROCE
|
-3.17 % | 18.02 % | 37.65 % |
5yr Avg Operating Profit Margin
|
0.0 | 14.19 % | 4.76 % |
5 yr average Debt to Equity
|
0.01 | 0.99 | 1.78 |
5yr CAGR Net Profit
|
n/a | 20.11 % | 3.81 % |
5yr Average Return on Assets
|
-4.13 % | 6.19 % | 6.13 % |
Shareholdings
|
|||
Promoter Holding
|
27.89 % | 71.99 % | 73.02 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Chemo Pharma Labs
|
Hamps Bio
|
Saroja Pharma Ind
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|